A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
- 18 October 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 18 (1), 37-50
- https://doi.org/10.1093/europace/euv304
Abstract
At least 30 million people worldwide carry a diagnosis of atrial fibrillation (AF), and many more suffer from undiagnosed, subclinical, or ‘silent’ AF. Atrial fibrillation-related cardiovascular mortality and morbidity, including cardiovascular deaths, heart failure, stroke, and hospitalizations, remain unacceptably high, even when evidence-based therapies such as anticoagulation and rate control are used. Furthermore, it is still necessary to define how best to prevent AF, largely due to a lack of clinical measures that would allow identification of treatable causes of AF in any given patient. Hence, there are important unmet clinical and research needs in the evaluation and management of AF patients. The ensuing needs and opportunities for improving the quality of AF care were discussed during the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference in Nice, France, on 22 and 23 January 2015. Here, we report the outcome of this conference, with a focus on (i) learning from our ‘neighbours’ to improve AF care, (ii) patient-centred approaches to AF management, (iii) structured care of AF patients, (iv) improving the quality of AF treatment, and (v) personalization of AF management. This report ends with a list of priorities for research in AF patients.Funding Information
- AFNET
- EHRA (01GI0204)
This publication has 140 references indexed in Scilit:
- Novel genetic markers improve measures of atrial fibrillation risk predictionEuropean Heart Journal, 2013
- Symptomatic Response to Antiarrhythmic Drug Therapy Is Modulated by a Common Single Nucleotide Polymorphism in Atrial FibrillationJournal of the American College of Cardiology, 2012
- High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trialEuropean Heart Journal, 2011
- Validation of an Atrial Fibrillation Risk Algorithm in Whites and African AmericansJAMA Internal Medicine, 2010
- Genome-wide association study of PR intervalNature Genetics, 2010
- Stroke Associated with Atrial Fibrillation – Incidence and Early Outcomes in the North Dublin Population Stroke StudyCerebrovascular Diseases, 2009
- Long-term Outcomes in Individuals With Prolonged PR Interval or First-Degree Atrioventricular BlockJAMA, 2009
- Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort studyThe Lancet, 2009
- The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial managementEP Europace, 2008
- Atrial Natriuretic Peptide Frameshift Mutation in Familial Atrial FibrillationThe New England Journal of Medicine, 2008